发明申请
US20110245102A1 Gene Expression Profiling of EGFR Positive Cancer 失效
EGFR阳性癌基因表达谱

Gene Expression Profiling of EGFR Positive Cancer
摘要:
The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
公开/授权文献
信息查询
0/0